We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
AMN Healthcare's Advanced Mobile App to Aid Travel Clinicians
Read MoreHide Full Article
AMN Healthcare Services, Inc. (AMN - Free Report) recently launched the latest version of AMN Passport — the most powerful and practical mobile app — that will enable travel nurses and allied professionals to find, book and manage their assignments. The company’s new offering will help clinicians with the healthcare industry’s most all-inclusive and easiest-to-use application for their mobile devices.
The introduction of this newest version of AMN Passport is likely to provide further boost to the company’s broad service portfolio.
Benefits of AMN Passport
Notably, this application aids clinicians to primarily personalize job preferences, manage an update credentials and professional profiles, thereby improving healthcare professionals’ experience.
AMN Healthcare — a leader and innovator in healthcare total talent services — remains focused in offering the best possible experience to its clinicians and continues to enhance AMN Passport in order to maximize the professional and personal experience of their assignments.
Recent Development
In June 2020, AMN Healthcare introduced a personalized, technology-enabled and clinically based service for businesses and other organizations that will help them in protecting the health and safety of employees as they return to work. The company’s return-to-work solutions offer each employer all the required staffing and protocols, which comprise temperature checks, COVID-19 testing, onsite clinic support, quarantine management and a telehealth platform.
Market Prospects
Per a report by Allied Market Research, the global healthcare IT (HCIT) market estimates that the market for HCIT solutions and services was $125 billion in 2015 and is projected to reach $297 billion by 2022, witnessing a CAGR of 13.2%.
Growing demand for quality healthcare services and solutions together with patient safety & care, proactive supportive government initiatives, and increase in acceptance of mHealth & telehealth practices have been driving this market. Further, growing adoption of smartphones is bolstering healthcare IT market growth.
Hence, the introduction of this new version of the mobile app is a well-timed one.
Price Performance
Over the past year, shares of this Zacks Rank #2 (Buy) company have lost 5.7% against the industry’s rally of 19.3%.
Other Stocks to Consider
Some other top-ranked stocks from the broader medical space include West Pharmaceutical Services, Inc. (WST - Free Report) , Thermo Fisher Scientific Inc. (TMO - Free Report) and PerkinElmer, Inc. . While PerkinElmer sports a Zacks Rank of 1 (Strong Buy), both West Pharmaceuticals and Thermo Fisher carry a Zacks Rank #2. You can seethe complete list of today’s Zacks #1 Rank stocks here.
PerkinElmer has a projected long-term earnings growth rate of 17.4%.
West Pharmaceutical has a projected long-term earnings growth rate of 17.4%.
Thermo Fisher has an estimated long-term earnings growth rate of 15%.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through Q2 2020, while the S&P 500 gained an impressive +44.0%, five of our strategies returned +50.9%, +93.8%, +122.2%, +153.0%, and even +156.8%.
This outperformance has not just been a recent phenomenon. From 2000 – Q2 2020, while the S&P averaged +5.5% per year, our top strategies averaged up to +51.7% per year.
Image: Bigstock
AMN Healthcare's Advanced Mobile App to Aid Travel Clinicians
AMN Healthcare Services, Inc. (AMN - Free Report) recently launched the latest version of AMN Passport — the most powerful and practical mobile app — that will enable travel nurses and allied professionals to find, book and manage their assignments. The company’s new offering will help clinicians with the healthcare industry’s most all-inclusive and easiest-to-use application for their mobile devices.
The introduction of this newest version of AMN Passport is likely to provide further boost to the company’s broad service portfolio.
Benefits of AMN Passport
Notably, this application aids clinicians to primarily personalize job preferences, manage an update credentials and professional profiles, thereby improving healthcare professionals’ experience.
AMN Healthcare — a leader and innovator in healthcare total talent services — remains focused in offering the best possible experience to its clinicians and continues to enhance AMN Passport in order to maximize the professional and personal experience of their assignments.
Recent Development
In June 2020, AMN Healthcare introduced a personalized, technology-enabled and clinically based service for businesses and other organizations that will help them in protecting the health and safety of employees as they return to work. The company’s return-to-work solutions offer each employer all the required staffing and protocols, which comprise temperature checks, COVID-19 testing, onsite clinic support, quarantine management and a telehealth platform.
Market Prospects
Per a report by Allied Market Research, the global healthcare IT (HCIT) market estimates that the market for HCIT solutions and services was $125 billion in 2015 and is projected to reach $297 billion by 2022, witnessing a CAGR of 13.2%.
Growing demand for quality healthcare services and solutions together with patient safety & care, proactive supportive government initiatives, and increase in acceptance of mHealth & telehealth practices have been driving this market. Further, growing adoption of smartphones is bolstering healthcare IT market growth.
Hence, the introduction of this new version of the mobile app is a well-timed one.
Price Performance
Over the past year, shares of this Zacks Rank #2 (Buy) company have lost 5.7% against the industry’s rally of 19.3%.
Other Stocks to Consider
Some other top-ranked stocks from the broader medical space include West Pharmaceutical Services, Inc. (WST - Free Report) , Thermo Fisher Scientific Inc. (TMO - Free Report) and PerkinElmer, Inc. . While PerkinElmer sports a Zacks Rank of 1 (Strong Buy), both West Pharmaceuticals and Thermo Fisher carry a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
PerkinElmer has a projected long-term earnings growth rate of 17.4%.
West Pharmaceutical has a projected long-term earnings growth rate of 17.4%.
Thermo Fisher has an estimated long-term earnings growth rate of 15%.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through Q2 2020, while the S&P 500 gained an impressive +44.0%, five of our strategies returned +50.9%, +93.8%, +122.2%, +153.0%, and even +156.8%.
This outperformance has not just been a recent phenomenon. From 2000 – Q2 2020, while the S&P averaged +5.5% per year, our top strategies averaged up to +51.7% per year.
See their latest picks free >>